Applikon Biotech has entered into an agreement with Niro Soavi for
the distribution of lab-scale homogenisers to the fermentation
market in North America.
CTG, a specialist in validation and verification information
technology and good automated manufacturing practices, has set up a
consultancy to serve companies in the life sciences sector.
A new range of cell culture vessels developed by Switzerland's
Integra Biosciences promises to increase production yields in
laboratories making monoclonal antibodies and recombinant proteins.
Roche has licensed exclusive marketing rights outside the USA to
Avastin (bevacizumab), a drug for colorectal cancer, from
Genentech. The latter company will retain all rights to the drug in
its home market.
Schering has been granted approval throughout the European Union
for Angeliq (oestradiol and drospirenone), its new low-dose hormone
replacement therapy.
Millipore launches a software suite of that helps users comply with
GLP when using its water purifiers; also unveils new Storage &
Distribution System.
Australia's Biotechnology Frontiers is awarded a A$780,000 grant to
develop a microbiological quality control tool that can be used in
the pharma and food industries.
Akzo Nobel received a knock-back from the US Food and Drug
Administration after the agency asked for more information before
approving a ready-to-use version of the firm's fertility drug
Follistim.
The Futura Safety Syringe, developed by UK company Medisys, has
successfully passed its final specification tests and should be
ready for launch within the next two months
Argonaut Technologies has introduced a new resin-bound reagent,
MP-TsO-TEMPO that enables medicinal chemists to introduce diversity
into chemical libraries with high purity and yields.
A new formulation of GlaxoSmithKline's Parkinson's disease drug
Requip (ropinirole), developed with UK drug delivery specialist
SkyePharma, has entered Phase III testing.
